Subscribe: FT.com - Health
http://news.ft.com/rss/companies/drugs
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
actelion  alzheimer’s  biotech  clinical  company  dementia  drug trials  health  healthcare  independent  news  results  science  shares  swiss 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: FT.com - Health

Health



Latest drugs and health news



Published: Fri, 02 Dec 2016 23:06:32 GMT

Last Build Date: Sat, 03 Dec 2016 21:56:08 GMT

Copyright: © Copyright The Financial Times Ltd 2016. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.
 



Week in Review, December 3

Fri, 02 Dec 2016 23:06:32 GMT

Glencore, Valeant, Airbnb, BT, and insurers facing higher asbestos payouts in the news



Apple loses key health team executive

Fri, 02 Dec 2016 21:12:38 GMT

Yoky Matsuoka’s exit is blow to chief Tim Cook who has made healthcare a priority



Actelion’s Clozel aims to keep group’s independence

Fri, 02 Dec 2016 17:32:01 GMT

Biotech company chief’s science background comes into play in face of J&J bid



Britain’s EU patent opt-in

Thu, 01 Dec 2016 13:19:37 GMT

Decision offers a cheaper and easier way to protect intellectual property



Valeant’s talks to sell Salix unit break down

Wed, 30 Nov 2016 17:21:26 GMT

Shares in Canadian drugmaker tumble after discussions with Japan’s Takeda collapse



Novo Nordisk shares rally on insulin trial results

Wed, 30 Nov 2016 16:21:59 GMT

Study confirms Tresiba can be safely used by diabetics with heart conditions



Fight against Alzheimer’s shows symptoms of failure

Wed, 30 Nov 2016 15:35:13 GMT

Failed drug trials have led some scientists to doubt theory behind disease



Gratitude is good for you in the festive season

Wed, 30 Nov 2016 13:31:08 GMT

Science backs counting your blessings



Drugmakers step out from behind their high walls

Tue, 29 Nov 2016 12:00:11 GMT

Era of isolation gives way to desire for greater collaboration



‘Brain training’ games target dementia

Tue, 29 Nov 2016 12:00:11 GMT

Flourishing industry focuses on science in attempt to shake off image of ‘snake oil salesmen’



Surgery embraces a world of smart robots

Tue, 29 Nov 2016 12:00:11 GMT

Technological progress points to power shift in the operating theatre



DNA editing accelerates along its controversial path

Tue, 29 Nov 2016 12:00:10 GMT

New techniques widen scope of genetic manipulation



Need for speed impels diagnostic advances

Tue, 29 Nov 2016 12:00:10 GMT

Simpler test procedures, increased accuracy and faster delivery of results are crucial



Genome sequencing makes way out of lab into clinical practice

Tue, 29 Nov 2016 12:00:10 GMT

Some two decades on, the discipline comes of age



Big data promise exponential change

Tue, 29 Nov 2016 12:00:10 GMT

Information explosion excites both experts and worries about privacy



Plaques, tangles and the mystery of Alzheimer’s

Tue, 29 Nov 2016 05:00:23 GMT

Dementia affects many millions but a cure is as elusive as ever



Murdoch faces huge writedown on Theranos investment

Tue, 29 Nov 2016 03:39:42 GMT

Media tycoon had risked about $100m of his own money in blood-testing start-up



Australia’s GenesisCare looks to UK for growth

Tue, 29 Nov 2016 01:07:17 GMT

Healthcare provider to spend £100m as NHS outsources clinical services



Actelion weighs complex deal with part of J&J

Mon, 28 Nov 2016 17:55:11 GMT

Structured transaction would see Swiss company remain independent



Actelion: independent thinking

Mon, 28 Nov 2016 16:54:28 GMT

Swiss biotech has rebuffed suitors before, but this one may be harder to turn down